Lactobacillus Rhamnosus and Women's Weight: An Honest Read of the Evidence

If you've looked into probiotics for weight management specifically in women, you've probably run into Lactobacillus rhamnosus — usually accompanied by a claim that it "worked in women but not men." That claim traces back to one real trial. Here's what the trial actually measured and where its findings are stronger or weaker than the shorthand suggests.

The short version

A 2014 Canadian trial using a specific L. rhamnosus strain (CGMCC1.3724) in overweight adults reported a sex-specific result: the women receiving the probiotic lost about twice as much weight as the women on placebo over 24 weeks (an average of 5.2 kg versus roughly half that), while the men in the same trial showed no difference between groups. The absolute gap in the women was a couple of kilograms, not transformative, and the trial was a single study of 125 people. "Works for women, not men" is not quite right as a summary; "showed a sex-specific signal in one trial that has not been robustly replicated" is closer.

What the Canadian trial actually looked at

The trial recruited 125 overweight men and women and randomized them to two capsules a day of the L. rhamnosus CGMCC1.3724 strain or placebo. Everyone followed a 12-week weight-loss diet, then a 12-week period aimed at maintaining weight, which is relevant context: the probiotic wasn't being tested in isolation but alongside a diet. After the diet phase, women on the probiotic had lost an average of 4.4 kg versus 2.6 kg on placebo. During maintenance, the placebo women's weight stayed stable while the probiotic women kept losing, reaching 5.2 kg in total. The men on the probiotic did not separate from the men on placebo; the researchers themselves said they did not know why, and suggested dose or study length as possibilities.

That sex-specific signal is interesting and biologically plausible — hormonal effects on appetite regulation and gut microbial composition differ between men and women on average — but it's one trial, with a specific strain, in a specific population, alongside a weight-loss diet. The follow-up research base on this specific strain and this specific effect is thinner than the amount of marketing citing the trial would suggest.

Where the honest hedges are

Four worth keeping in mind. First, the trial was conducted in a weight-loss context (a diet was part of the protocol), so the probiotic was shown to add to a diet, not to produce weight change on its own. Removing the diet doesn't remove the probiotic, but it does remove the mechanism the trial actually tested. Second, the strain used belongs to a large food company that sells it in some of its own yogurts in Europe; the coverage we reviewed did not say who funded the trial, so we cannot tell you whether the manufacturer was involved. Third, as with most probiotic research, the strain identifier matters more than the species name — a bottle labeled L. rhamnosus without a strain code is not necessarily the CGMCC1.3724 strain, and the two are not equivalent. Fourth, there's a well-known pattern across perimenopause and menopause that complicates any "worked in women" claim, because the "women" in a given trial span life stages with meaningfully different physiology. Age and hormonal status may be confounded with sex in the effect the trial reported.

What tends to help

For anyone weighing L. rhamnosus as part of a broader approach, the practical reads are these. Combining a probiotic with modest dietary change tends to outperform either in isolation in the research, and the Canadian trial reflects that pattern. Expect effects on the order of the trial — modest, over weeks, measurable but not large. And if sex-specific effects are relevant to the reason you're considering it, read the label for the actual strain, because that's the only way the research is portable to the product.

We earn an affiliate commission when you buy through our links. That commission never influences what makes the shortlist — see our disclosure below.

The bottom line

Lactobacillus rhamnosus has one notable weight trial in women that reported a sex-specific effect — real, modest, and in the context of a weight-loss diet. "Works for women" oversells it; "one trial, specific strain, specific context, worth a hedged read" is closer. Strain identification on the label is the main thing that decides whether the research applies to the product in your hand.

These statements have not been evaluated by the Food and Drug Administration. The products discussed on this site are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease. Consult your physician before beginning any supplement program, particularly if you are pregnant, nursing, taking medication, or managing a medical condition. Individual results vary.